找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Resistant Hypertension in Chronic Kidney Disease; Adrian Covic,Mehmet Kanbay,Edgar V. Lerma Book 2017 Springer International Publishing AG

[復(fù)制鏈接]
樓主: energy
21#
發(fā)表于 2025-3-25 06:07:36 | 只看該作者
Resistant Hypertension in Elderly People with Chronic Kidney Disease,deed, around 60% of those aged 80 years or older have chronic kidney disease. Thus, population studies in such elderly individuals probably reflect individuals with chronic kidney disease. During aging both systolic blood pressure and pulse pressure progressively increase. It is important to note th
22#
發(fā)表于 2025-3-25 10:00:14 | 只看該作者
Obstructive Sleep Apnea and Resistant Hypertension,everal factors, including obesity, are common to both disorders, a large body of evidence accumulated over several years supports OSA as having an independent and causal role in precipitating and perpetuating hypertension..Both OSA and resistant hypertension are associated with increased cardiovascu
23#
發(fā)表于 2025-3-25 12:55:16 | 只看該作者
24#
發(fā)表于 2025-3-25 19:30:40 | 只看該作者
Public Health Efforts for Earlier Resistant Hypertension Diagnosis, Reduction of Salt Content in Fo being a diuretic at full doses, blood pressure remains uncontrolled. Firstly, it should be confirmed that the patients with resistant hypertension do have true RHT; this can be done by ruling out or correcting factors associated with pseudo-resistance which contain an inaccurate measurement of bloo
25#
發(fā)表于 2025-3-25 23:27:51 | 只看該作者
Treatment of Hypertension in Light of the New Guidelines: Salt Intake,cally rises with decline in kidney function, and sustained elevations in BP hasten progression of kidney disease. Hypertension in patients with CKD is often accompanied by a decrease in the kidney’s ability to remove salt. Addressing this salt sensitivity is critical for the management of HT in CKD
26#
發(fā)表于 2025-3-26 03:49:14 | 只看該作者
27#
發(fā)表于 2025-3-26 07:21:56 | 只看該作者
Treatment of Hypertension in Light of the New Guidelines: Pharmacologic Approaches Using CombinatioD), since these patients have usually been excluded from randomized controlled trials (RCTs) in hypertension. Combined therapy, however, has to be individualized, depending on the patient’s pathophysiologic profile, comorbidities, and contraindications. The optimal combination should be well tolerat
28#
發(fā)表于 2025-3-26 12:33:29 | 只看該作者
Devices for Neural Modulation (Renal Denervation, Barostimulation),m (SNS). Kidneys are innervated by two types of fibers the sensory afferent fibers leading from the central nervous system to the kidneys and sympathetic efferent fibers which start in the kidneys and run to the central nervous system. Results of experimental and clinical studies suggest that affere
29#
發(fā)表于 2025-3-26 14:56:19 | 只看該作者
30#
發(fā)表于 2025-3-26 19:03:57 | 只看該作者
Treatment of Hypertension in Light of the New Guidelines: Salt Intake,and dietary salt restriction and appropriate diuretic therapy make up the mainstay of HT treatment in patients with CKD. This chapter reviews the importance of salt in pathogenesis and maintenance of HT in CKD and the role of salt restriction in controlling HT in CKD.
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-12 20:25
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
新民市| 彰化县| 宣汉县| 商都县| 绥棱县| 贺兰县| 灌南县| 南开区| 砚山县| 肃宁县| 柳州市| 航空| 焦作市| 商洛市| 牙克石市| 紫金县| 永胜县| 故城县| 洪湖市| 德钦县| 衡南县| 晴隆县| 新乡县| 凌海市| 林芝县| 陵川县| 聂荣县| 湟中县| 长乐市| 乌兰县| 西乌珠穆沁旗| 江门市| 明星| 抚顺市| 新巴尔虎左旗| 金川县| 贡山| 丰宁| 霍州市| 临泉县| 白玉县|